The Relationship between Type 1 Diabetes Mellitus, TNF-α, and IL-10 Gene Expression
Authors:
- Jesselina Francisco dos Santos HaberJHJesselina Francisco dos Santos Haber
- Sandra Maria BarbalhoSandra Maria Barbalho
- Jose Augusto SgarbiJSJose Augusto Sgarbi
- Rafael Santos de Argollo HaberRHRafael Santos de Argollo Haber
- Roger William de LabioRLRoger William de Labio
- Lucas Fornari LaurindoLucas Fornari Laurindo
- Eduardo Federighi Baisi ChagasECEduardo Federighi Baisi Chagas
- Spencer Luiz Marques PayãoSPSpencer Luiz Marques Payão
Open Access
- 7 April 2023
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 11 (4) , 1120
Abstract
Type 1 diabetes mellitus (T1DM) is one of the major chronic diseases in children worldwide. This study aimed to investigate interleukin-10 (IL-10) gene expression and tumor necrosis factor-alpha (TNF-α) in T1DM. A total of 107 patients were included, 15 were T1DM in ketoacidosis, 30 patients had T1DM and HbA1c ≥ 8%; 32 patients had T1DM and presented HbA1c < 8%; and 30 were controls. The expression of peripheral blood mononuclear cells was performed using the reverse transcriptase–polymerase chain reaction in real time. The cytokines gene expression was higher in patients with T1DM. The IL-10 gene expression increased substantially in patients with ketoacidosis, and there was a positive correlation with HbA1c. A negative correlation was found for IL-10 expression and the age of patients with diabetes, and the time of diagnosis of the disease. There was a positive correlation between TNF-α expression with age. The expression of IL-10 and TNF-α genes showed a significant increase in DM1 patients. Once current T1DM treatment is based on exogenous insulin, there is a need for other therapies, and inflammatory biomarkers could bring new possibilities to the therapeutic approach of the patients.Keywords
Funding Information
- CAPES
This publication has 65 references indexed in Scilit:
- Immunological pathways to β‐cell damage in Type 1 diabetesDiabetic Medicine, 2013
- The Role of TNF-α in Mice with Type 1- and 2- DiabetesPLOS ONE, 2012
- A new role for interleukin‐10 in immune regulationImmunology & Cell Biology, 2010
- Heterogeneidade do diabetes melito tipo 1Archives of Endocrinology and Metabolism, 2008
- Pathogenicity of T helper 2 T-cell clones from T-cell receptor transgenic non-obese diabetic mice is determined by tumour necrosis factor-αImmunology, 2008
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- The Temporal Importance of TNFα Expression in the Development of DiabetesImmunity, 2000
- Decreased Secretion of Th2 Cytokines Precedes Up-regulated and Delayed Secretion of Th1 Cytokines in Activated Peripheral Blood Mononuclear Cells from Patients with Insulin-Dependent Diabetes MellitusJournal of Autoimmunity, 1998
- Effect of tumor necrosis factor alpha on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process.Journal of Experimental Medicine, 1994
- Production of interleukin 10 by islet cells accelerates immune-mediated destruction of beta cells in nonobese diabetic mice.Journal of Experimental Medicine, 1994